CPEB1, a novel gene silenced in gastric cancer: A Drosophila approach

Gut

Volumn 61, Issue 8, 2012, Pages 1115-1123

  Caldeira, Joana ^a,b,c   Simões Correia, Joana ^a,d   Paredes, Joana ^a,b   Pinto, Marta T ^a   Sousa, Sónia ^a   Corso, Giovanni ^a,e,f   Marrelli, Daniele ^e,f   Roviello, Franco ^e,f   Pereira, Paulo S ^g   Weil, Dominique ^h   Oliveira, Carla ^a,b   Casares, Fernando ^c   Seruca, Raquel ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c Departamento de Biología Molecular e Ingeniería Bioquímica   (Spain)

^d UNIVERSITY OF COIMBRA   (Portugal)

^e UNIVERSITY OF SIENA   (Italy)

^f ISTITUTO TOSCANO TUMORI   (Italy)

^g UNIVERSITY OF PORTO   (Portugal)

^h SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BMP2 GENE; CDC16 GENE; CONTROLLED STUDY; CPEB1 GENE; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; DROSOPHILA; EPIGENETICS; GENE EXPRESSION; GENE FREQUENCY; GENE SILENCING; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MEF2A GENE; MMP14 GENE; MOLECULAR DYNAMICS; MUTATIONAL ANALYSIS; NONHUMAN; ONCOGENE; PAM GENE; POLYADENYLATION; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SLC17A5 GENE; STOMACH CANCER; TRANSGENE; VEGFA GENE;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; DNA METHYLATION; DROSOPHILA; DROSOPHILA PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; MUTATION; NEOPLASMS, EXPERIMENTAL; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 84863719147     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-300427     Document Type: Article

References (51)

1. Caldas C, Carneiro F, Lynch HT, et al. Familial gastric cancer: overview and guidelines for management. J Med Genet 1999;36:873-80. (Pubitemid 30003842)
2. Dunbier A, Guilford P. Hereditary diffuse gastric cancer. Adv Cancer Res 2001;83:55-65. (Pubitemid 32959261)
3. Milne AN, Sitarz R, Carvalho R, et al. Early onset gastric cancer: on the road to unraveling gastric carcinogenesis. Curr Mol Med 2007;7:15-28. (Pubitemid 46322276)
4. Pinheiro H, Bordeira-Carrico R, Seixas S, et al. Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer. Hum Mol Genet 2010;19:943-52.
5. Oliveira C, Sousa S, Pinheiro H, et al. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology 2009;136:2137-48.
6. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 1993;5:806-11.
7. Mateus AR, Simoes-Correia J, Figueiredo J, et al. E-cadherin mutations and cell motility: a genotype-phenotype correlation. Exp Cell Res 2009;315:1393-402.
8. Suriano G, Oliveira C, Ferreira P, et al. Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Hum Mol Genet 2003;12:575-82. (Pubitemid 36305595)
9. Birchmeier W, Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1994;1198:11-26. (Pubitemid 24159061)
10. Christofori G, Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 1999;24:73-6. (Pubitemid 29346577)
11. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002;2:442-54.
12. Oliveira C, Seruca R, Carneiro F. Genetics, pathology, and clinics of familial gastric cancer. Int J Surg Pathol 2006;14:21-33. (Pubitemid 43221612)
13. Hirth F. Drosophila melanogaster in the study of human neurodegeneration. CNS Neurol Disord Drug Targets 2010;9:504-23.
14. Daczewska M, Picchio L, Jagla T, et al. Muscle development and regeneration in normal and pathological conditions: learning from Drosophila. Curr Pharm Des 2010;16:929-41.
15. O'Callaghan D, Vergunst A. Non-mammalian animal models to study infectious disease: worms or fly fishing? Curr Opin Microbiol 2010;13:79-85.
16. Neely GG, Kuba K, Cammarato A, et al. A global in vivo Drosophila RNAi screen identifies NOT3 as a conserved regulator of heart function. Cell 2010;141:142-53.
17. Brumby AM, Richardson HE. Using Drosophila melanogaster to map human cancer pathways. Nat Rev Cancer 2005;5:626-39. (Pubitemid 41081388)
18. Potter CJ, Turenchalk GS, Xu T. Drosophila in cancer research. An expanding role. Trends Genet 2000;16:33-9. (Pubitemid 30062236)
19. Toba G, Ohsako T, Miyata N, et al. The gene search system. A method for efficient detection and rapid molecular identification of genes in Drosophila melanogaster. Genetics 1999;151:725-37. (Pubitemid 29082939)
20. St Johnston D. The art and design of genetic screens: Drosophila melanogaster. Nat Rev Genet 2002;3:176-88. (Pubitemid 34506586)
21. Caldeira J, Pereira PS, Suriano G, et al. Using fruitflies to help understand the molecular mechanisms of human hereditary diffuse gastric cancer. Int J Dev Biol 2009;53:1557-61.
22. Pereira PS, Teixeira A, Pinho S, et al. E-cadherin missense mutations, associated with hereditary diffuse gastric cancer (HDGC) syndrome, display distinct invasive behaviors and genetic interactions with the Wnt and Notch pathways in Drosophila epithelia. Hum Mol Genet 2006;15:1704-12. (Pubitemid 43904836)
23. Molnar C, Lopez-Varea A, Hernandez R, et al. A gain-of-function screen identifying genes required for vein formation in the Drosophila melanogaster wing. Genetics 2006;174:1635-59. (Pubitemid 44808329)
24. Brand AH, Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 1993;118:401-15. (Pubitemid 23214028)
25. Freeman M. Reiterative use of the EGF receptor triggers differentiation of all cell types in the Drosophila eye. Cell 1996;87:651-60. (Pubitemid 26386939)
26. Kaltschmidt JA, Davidson CM, Brown NH, et al. Rotation and asymmetry of the mitotic spindle direct asymmetric cell division in the developing central nervous system. Nat Cell Biol 2000;2:7-12.
27. Serman A, Le Roy F, Aigueperse C, et al. GW body disassembly triggered by siRNAs independently of their silencing activity. Nucleic Acids Res 2007;35:4715-27. (Pubitemid 47250343)
28. Yabuta T, Shinmura K, Tani M, et al. E-cadherin gene variants in gastric cancer families whose probands are diagnosed with diffuse gastric cancer. Int J Cancer 2002;101:434-41.
29. Suriano G, Mulholland D, de Wever O, et al. The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell-cell adhesion and to suppress invasion. Oncogene 2003;22:5716-19. (Pubitemid 37102710)
30. Oda T, Kanai Y, Oyama T, et al. E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci U S A 1994;91:1858-62. (Pubitemid 24080305)
31. Jawhari AU, Noda M, Farthing MJ, et al. Abnormal expression and function of the E-cadherin-catenin complex in gastric carcinoma cell lines. Br J Cancer 1999;80:322-30. (Pubitemid 29213180)
32. Cameron EE, Bachman KE, Myohanen S, et al. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 1999;21:103-7. (Pubitemid 29036293)
33. Geiger TR, Peeper DS. Metastasis mechanisms. Biochim Biophys Acta 2009;1796:293-308.
34. Bazas VM, Lukyanova NY, Demash DV, et al. Relation between cell-to-cell adhesion and angiogenesis and clinico-morphological prognostic factors in patients with gastric cancer. Exp Oncol 2008;30:235-9.
35. Barrett T, Troup DB, Wilhite SE, et al. NCBI GEO: archive for high-throughput functional genomic data. Nucleic Acids Res 2009;37:D885-90.
36. Provenzani A, Fronza R, Loreni F, et al. Global alterations in mRNA polysomal recruitment in a cell model of colorectal cancer progression to metastasis. Carcinogenesis 2006;27:1323-33. (Pubitemid 43985407)
37. Varambally S, Yu J, Laxman B, et al. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 2005;8:393-406. (Pubitemid 41579834)
38. Genis L, Galvez BG, Gonzalo P, et al. MT1-MMP: universal or particular player in angiogenesis? Cancer Metastasis Rev 2006;25:77-86. (Pubitemid 43723984)
39. Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2002;2:795-803. (Pubitemid 37328914)
40. Hansen CN, Ketabi Z, Rosenstierne MW, et al. Expression of CPEB, GAPDH and U6snRNA in cervical and ovarian tissue during cancer development. APMIS 2009;117:53-9.
41. Heller G, Schmidt WM, Ziegler B, et al. Genome-wide transcriptional response to 5-aza-2′-deoxycytidine and trichostatin a in multiple myeloma cells. Cancer Res 2008;68:44-54. (Pubitemid 351380104)
42. Welk JF, Charlesworth A, Smith GD, et al. Identification and characterization of the gene encoding human cytoplasmic polyadenylation element binding protein. Gene 2001;263:113-20. (Pubitemid 32167060)
43. Mendez R, Richter JD. Translational control by CPEB: a means to the end. Nat Rev Mol Cell Biol 2001;2:521-9. (Pubitemid 33673402)
44. Paris J, Richter JD. Maturation-specific polyadenylation and translational control: diversity of cytoplasmic polyadenylation elements, influence of poly(A) tail size, and formation of stable polyadenylation complexes. Mol Cell Biol 1990;10:5634-45.
45. Zhang JH, Panicker LM, Seigneur EM, et al. Cytoplasmic polyadenylation element binding protein is a conserved target of tumor suppressor HRPT2/CDC73. Cell Death Differ 2010;17:1551-65.
46. Burns DM, Richter JD. CPEB regulation of human cellular senescence, energy metabolism, and p53 mRNA translation. Genes Dev 2008;22:3449-60.
47. Groisman I, Ivshina M, Marin V, et al. Control of cellular senescence by CPEB. Genes Dev 2006;20:2701-12. (Pubitemid 44498380)
48. Ming SC. Gastric carcinoma. A pathobiological classification. Cancer 1977;39:2475-85. (Pubitemid 8144816)
49. Nottingham J. Signet-ring carcinoma of stomach in a child. Histopathology 1994;24:490-1. (Pubitemid 24192323)
50. Hagele S, Kuhn U, Boning M, et al. Cytoplasmic polyadenylation-element- binding protein (CPEB)1 and 2 bind to the HIF-1alpha mRNA 3′-UTR and modulate HIF-1alpha protein expression. Biochem J 2009;417:235-46.
51. Ellis LM, Fidler IJ. Angiogenesis and metastasis. Eur J Cancer 1996;32A:2451-60.